Abstract | BACKGROUND: Tumor microenvironment is infiltrated by many immune cells, of which Regulatory T (Treg) cells are usually considered as negative regulators of the immune responses. However, the effect of FOXP3+ ( forkhead box transcription factor 3) Treg cells infiltrated into the tumor areas on the prognosis of breast cancer is controversial. This meta-analysis aimed to dissect the potential values of FOXP3+ tumor-infiltrating lymphocytes (TILs) as a prognosis predictor of breast cancer. METHODS: After systematic retrieval of all relevant studies, 28 eligible articles were identified for meta-analysis. Odd ratio (OR), hazard ratio (HR), and 95% confidence interval (CI) were obtained for pooled analyses of pathological complete response (pCR), overall survival (OS), and corresponding forest plots and funnel plots were plotted, respectively. RESULTS: Pooled results revealed that patients with higher levels of FOXP3+ TILs experienced better pCR (OR: 1.24, 95% CI 1.09-1.41) and OS (HR: 0.79, 95% CI 0.64-0.97). Subgroup analysis revealed that elevated FOXP3+ TILs were significantly associated with improved pCR (OR: 1.20, 95% CI 1.02-1.40) and OS (HR: 0.22, 95% CI 0.06-0.88) in human epidermal growth factor receptor 2 positive (HER2+) breast cancer patients. Furthermore, FOXP3+ TILs in the stromal area were statistically correlated with the favorable pCR (OR: 1.22, 95% CI 1.08-1.38) and OS (HR: 0.68, 95% CI 0.49-0.96). CONCLUSIONS: The predictive role of FOXP3+ TILs in the prognosis of breast cancer is influenced by various factors such as molecular subtype of breast cancer and the location of Treg. In HER2+ breast cancer and triple-negative breast cancer, FOXP3+ TILs are associated with better pCR and OS. Additionally, FOXP3+ TILs in stromal represent a favourable prognosis.
|
Authors | Yalan Sun, Ying Wang, Fang Lu, Xianghong Zhao, Zhenlin Nie, Bangshun He |
Journal | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
(Clin Transl Oncol)
Vol. 25
Issue 6
Pg. 1830-1843
(Jun 2023)
ISSN: 1699-3055 [Electronic] Italy |
PMID | 36692642
(Publication Type: Meta-Analysis, Systematic Review, Journal Article, Review)
|
Copyright | © 2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO). |
Chemical References |
- Forkhead Transcription Factors
- FOXP3 protein, human
|
Topics |
- Humans
- Female
- Breast Neoplasms
(pathology)
- Prognosis
- Lymphocytes, Tumor-Infiltrating
(metabolism)
- Triple Negative Breast Neoplasms
(pathology)
- T-Lymphocytes, Regulatory
(pathology)
- Forkhead Transcription Factors
(metabolism)
- Tumor Microenvironment
|